TScan Therapeutics Alternatives & Competitors

12 companies similar to TScan Therapeutics — Unleash Immunity

Legend Biotech

Multinational biopharmaceutical company focused on discovering and developing cutting-edge...

2565 Unknown $1.62B

Somerset, United States

Biotechnology Health Care +2

Allogene Therapeutics

A biotechnology company catalyzing cancer treatment through the development of CAR T thera...

214 IPO $1.05B

South San Francisco, Unit...

Biotechnology

Immune-Onc Therapeutics

Science at Our Core. Patients in Our Hearts.

14 Series B $140.14M

Palo Alto, United States

3T Biosciences

3T is an immunotherapy company developing next-generation, transformative therapies for br...

26 Series A $52.00M

South San Francisco, Unit...

Biopharma Biotechnology +1

Track all TScan Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Treeline

Making medicines at the highest level

172 Series A $473.27M

Watertown, United States

Biotechnology Health Care +1

克睿基因 Cure Genetics

Benifiting Lives with Genetic Engineering

15 Series B $95.50M

China

Biotechnology Health Care

Caribou Biosciences

Clinical-stage biopharmaceutical company developing transformative therapies to treat deva...

128 IPO $588.55M

Berkeley, United States

Biotechnology Health Care +1

T-knife Therapeutics

T-knife uses a mouse platform to create human TCRs for cancer treatment without modificati...

78 Series B $184.00M

San Francisco, United Sta...

PhotonPharma

An immuno-oncology company unleashing the body to fight cancer

8 Seed $4.30M

Fort Collins, United Stat...

Repertoire Immune Medicines

Repertoire is a biotechnology company creating a new category of immune medicines for canc...

86 Series B $189.00M

Cambridge, United States

Biotechnology Health and Wellness +1

Asylia Therapeutics

Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious...

1 Series A $14.50M

Biotechnology Health Care +1

Autolus Therapeutics

Focused on the development of precisely targeted, controlled & highly active T cell therap...

763 Post Ipo Equity $1.07B

London, United Kingdom

Biopharma Biotechnology +1

About TScan Therapeutics

Unleash Immunity

Services

Development of T-cell therapies, Genetically reprogramming T cells, Clinical trials for TCR-T therapy candidates, Anti-cancer TCR discovery

Target Customers

Cancer patients, Patients with hematologic malignancies, Patients with solid tumors, Patients with autoimmune diseases

Taxonomy

TCR-T Cell Therapy, T Cell Therapies, Biopharmaceutical, Hematologic Malignancies, Solid Tumors, Residual Leukemia, Hematopoietic Stem Cell Transplantation, Engineered T Cell Therapy, Automimmune Disorders, Infectious Diseases, Multiplexed Therapy, Oncology, Immune System, Therapeutic Platforms, Life Sciences Innovation

Business Model

B2B, B2C, B2D

Revenue Model

Licensing, Performance Based, Product Sales

Frequently Asked Questions

Top alternatives to TScan Therapeutics include Legend Biotech, Allogene Therapeutics, Immune-Onc Therapeutics, 3T Biosciences, Treeline. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to TScan Therapeutics based on industry overlap, target customers, and business model.

Unleash Immunity

Don't just read about them. Follow them.

BounceWatch watches TScan Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

TScan Therapeutics Profile Legend Biotech Alternatives Allogene Therapeutics Alternatives Immune-Onc Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at TScan Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 28 Jan 2026 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.